Concepedia

William Wesson

WW

Statistics

Publications

5

Citations

124

H-Index

5

Active since

2023

Affiliations

The University of Kansas Cancer Center(Current)

Medical University of South Carolina

University of Kansas Medical Center

Memorial Sloan Kettering Cancer Center

William Wesson is an author at The University of Kansas Cancer Center specializing in immunology, immunotherapy, and cell transplantation.

ORCID

Top concepts

Publications per year

2023–2024

5

Publications

5

Efficacy and Safety of CD34+ Stem Cell Boost for Delayed Hematopoietic Recovery After BCMA Directed CAR T-cell Therapy

James A. Davis, Douglas W. Sborov, William Wesson et al. · Transplantation and Cellular Therapy · 2023 · 42 citations

, , +10

Timing of Toxicities and Non-Relapse Mortality Following CAR T Therapy in Myeloma

William Wesson, Danai Dima, Nahid Suleman et al. · Transplantation and Cellular Therapy · 2024 · 28 citations · Full text

, , +20

Optimizing the post-CAR T monitoring period in recipients of axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucel

Nausheen Ahmed, William Wesson, Forat Lutfi et al. · Blood Advances · 2024 · 27 citations · Full text

Safety and efficacy of eltrombopag in patients with post‐<scp>CAR T</scp> cytopenias

William Wesson, Nausheen Ahmed, Aliya Rashid et al. · European Journal Of Haematology · 2023 · 14 citations · Full text

“Waitlist mortality” is high for myeloma patients with limited access to BCMA therapy

Nausheen Ahmed, William Wesson, Muhammad Umair Mushtaq et al. · Frontiers in Oncology · 2023 · 13 citations · Full text

1–5 of 5